CENCOMALLS:BCSCencosud Shopping SA Analysis
Data as of 2026-06-14 - not real-time
CLP 2,464.30
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
CENCOSUD Shopping SA trades at 2,464 CLP, comfortably above its DCF‑derived fair value of 1,612 CLP, suggesting the market is pricing in premium expectations. Valuation multiples such as a P/E of 12.5 are well below the industry average of 33.4, reflecting attractive earnings relative to peers, while the price‑to‑book of 1.37 indicates modest premium over net asset value. Technical signals are mixed: the 20‑day SMA (2,387) sits just below the current price, the RSI at 53.7 signals a neutral stance, and a bullish MACD histogram (+9.9) points to short‑term upward momentum despite a neutral overall trend. The stock offers a solid dividend yield of 3.04% with a payout ratio of 46%, supported by strong operating cash flow (280 B CLP) and free cash flow (213 B CLP). However, the balance sheet is heavily leveraged, with a debt‑to‑equity of 26.5, raising concerns about long‑term financial flexibility. Volatility remains elevated at 35.6% over the past 30 days, though beta is modest (0.48), indicating limited systematic risk. The market sentiment index is in “Extreme Greed” territory (89.86), which may be inflating the price further. Given these dynamics, the stock presents a blend of value appeal via earnings and dividend income, but the premium valuation and debt load warrant caution. Investors should monitor the support level at 2,235 CLP and resistance near 2,738 CLP for potential breakout or pull‑back scenarios. Overall, the outlook favors a cautious stance, leveraging the dividend while awaiting clearer directional cues.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD histogram indicating short‑term momentum
- Price above 20‑day SMA offering near‑term support
- Strong dividend yield providing immediate income
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Upside potential of ~11% toward target price
- Attractive earnings multiple versus industry peers
- Stable cash flow supporting dividend sustainability
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High leverage may limit future financial flexibility
- Valuation premium above DCF fair value
- Consistent dividend payments offsetting valuation concerns
Key Metrics & Analysis
Financial Health
Revenue Growth4.80%
Profit Margin88.14%
P/E Ratio12.5
ROE11.29%
ROA4.77%
Debt/Equity26.54
P/B Ratio1.4
Op. Cash FlowCLP280.7B
Free Cash FlowCLP213.2B
Industry P/E33.4
Technical Analysis
TrendNeutral
RSI53.7
SupportCLP 2,235.00
ResistanceCLP 2,737.60
MA 20CLP 2,387.76
MA 50CLP 2,512.80
MA 200CLP 2,385.75
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair ValueCLP 1,612.34
Target PriceCLP 2,747.14
Upside/Downside11.48%
GradeOvervalued
TypeValue
Dividend Yield3.04%
Risk Assessment
Beta0.48
Volatility35.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.